Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 108,332 | 113,054 | 108,096 | 76,701 | 79,660 |
| Cost of Goods | 51,748 | 53,540 | 48,058 | 38,774 | 37,655 |
| Gross Profit | 56,584 | 59,514 | 60,038 | 37,927 | 42,005 |
| Operating Expenses | 44,663 | 46,727 | 51,549 | 50,303 | 41,274 |
| Operating Income | 11,921 | 12,787 | 8,489 | -12,376 | 731 |
| Interest Expense | 8,195 | 13,364 | 13,606 | 12,223 | 9,819 |
| Other Income | -2,286 | 683 | 76 | 20,779 | -22,413 |
| Pre-tax Income | 1,440 | 106 | -5,041 | -3,820 | -31,501 |
| Income Tax | -807 | 320 | -6,262 | -941 | -3,237 |
| Net Income Continuous | 2,247 | -214 | 1,221 | -2,879 | -28,264 |
| Net Income | $2,247 | $-214 | $1,221 | $-2,879 | $-28,264 |
| EPS Basic Total Ops | 0.09 | -0.01 | 0.06 | -0.15 | -1.86 |
| EPS Basic Continuous Ops | 0.09 | -0.01 | 0.06 | -0.15 | -1.86 |
| EPS Diluted Total Ops | 0.08 | -0.01 | 0.06 | -0.15 | -1.86 |
| EPS Diluted Continuous Ops | 0.08 | -0.01 | 0.06 | -0.15 | -1.86 |
| EBITDA(a) | $16,813 | $19,276 | $14,646 | $14,548 | $-15,704 |